Microcap Ledger

Tickers · $MLSS

Milestone Scientific Inc. $MLSS

By Microcap Ledger desk · CIK 0000855683

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
NYSE American
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Headquarters
Livingston, NJ
Fiscal year end
December 31
Shares outstanding
88,739,185 [10-Q 2026-08-13]
as of 2026-08-11

Sources: [10-K 2026-03-31]

What the company doesAI summary of filing

Milestone Scientific Inc. develops and commercializes computer-controlled drug delivery systems based on its proprietary Dynamic Pressure Sensing (DPS) Technology, which controls flow rate and measures pressure at the needle tip in real time. The company's products include dental systems marketed as CompuDent and STA Single Tooth Anesthesia System, sold in the United States, Canada, and over 40 other countries, and the CompuFlo Epidural Computer Controlled Anesthesia System for medical use, which received FDA 510(k) clearance in 2017 with expanded clearance in 2023. The company generates revenue from sales of these products through direct sales channels in the United States, e-commerce for dental products, and third-party distribution arrangements internationally. Milestone Scientific is revenue-generating, with established market presence in the dental sector and ongoing commercialization efforts in the medical market. [10-K 2026-03-31]

Segments: CompuDent/STA Single Tooth Anesthesia System (Dental), CompuFlo Epidural Computer Controlled Anesthesia System (Medical), The Wand (Dental handpiece), DPS Dynamic Pressure Sensing Technology Platform

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$5.00M−$1.90M −$498.3K$2.07M[10-Q 2026-08-13]
FY ended Dec 2025$8.97M$5.72M −$2.92M$1.10M[10-K 2026-03-31]
FY ended Dec 2024$8.63M$4.71M −$2.92M$3.26M[10-K 2026-03-31]
Quarterly cash burn
−$249.1K
Cash runway Estimate
~24.9 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-1477,892,083[10-Q 2024-11-14]
2025-04-1578,379,633[10-K 2025-04-15]
2025-05-1478,477,320[10-Q 2025-05-15]
2025-08-1478,559,147[10-Q 2025-08-14]
2025-11-1278,628,913[10-Q 2025-11-13]
2026-03-3180,453,116[10-K/A 2026-05-05]
2026-05-1188,075,170[10-Q 2026-05-13]
2026-08-1188,739,185[10-Q 2026-08-13]
Shelf registration
S-3 filed 2026-09-08; declared effective 2026-09-28 [S-3 2026-09-08]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-10-14. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2025-10-148-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-10-14]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2025-10-24Bp4 S.R.L.sell100,000$0.44[4 2025-10-29]
2025-10-23Bp4 S.R.L.sell80,000$0.43[4 2025-10-29]
2025-10-22Bp4 S.R.L.sell14,427$0.45[4 2025-10-29]
2025-10-21Bp4 S.R.L.sell40,000$0.44[4 2025-10-23]
2025-10-20Bp4 S.R.L.sell24,034$0.45[4 2025-10-23]
2025-10-14Bp4 S.R.L.sell30,000$0.54[4 2025-10-17]
2025-10-13Bp4 S.R.L.sell10,000$0.55[4 2025-10-17]
2025-10-10Bp4 S.R.L.sell10,158$0.55[4 2025-10-17]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-09-18S-3/ARegistration statement
2026-09-08S-3Registration statement
2026-08-1310-QQuarterly report
2026-07-318-KDirector or officer change; Shareholder vote results
2026-07-298-KOther events
2026-06-258-KMaterial agreement entered; Director or officer change; Regulation FD disclosure
2026-06-22DEF 14AProxy statement
2026-06-09424B1Prospectus or prospectus supplement
2026-06-05PRE 14AProxy statement
2026-06-02S-3Registration statement
2026-05-1310-QQuarterly report
2026-05-068-KAuditor change

Facts as of . Small caps move fast; check the latest filings.